Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Non-Current Debt (2011 - 2026)

Mimedx recorded quarterly Non-Current Debt of $16.1 million in Q1 2026, down 2.27% quarter-over-quarter from $16.5 million in Q4 2025, and down 8.21% year-over-year from $17.5 million in Q1 2025.

Mimedx's Non-Current Debt history runs 10 years deep, the most recent figure standing at $16.1 million for Q1 2026.

  • In Q1 2026, Non-Current Debt fell 8.21% year-over-year to $16.1 million; the TTM figure through Mar 2026 stood at $16.1 million (down 8.21% YoY), while the FY2025 annual figure was $16.5 million, down 7.64% from the prior year.
  • Non-Current Debt came in at $16.1 million for Q1 2026 at Mimedx, down from $16.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $49.0 million in Q3 2023 to a low of $16.1 million in Q1 2026.
  • A 5-year average of $32.1 million and a median of $18.5 million in 2024 frame the typical range for Non-Current Debt.
  • Across the five-year window, Non-Current Debt gained 1.01% in 2023 and slumped 63.2% in 2024, its largest moves.
  • Mimedx's Non-Current Debt stood at $48.6 million in 2022, then dropped by 1.02% to $48.1 million in 2023, then slumped by 62.93% to $17.8 million in 2024, then dropped by 7.64% to $16.5 million in 2025, then slipped by 2.27% to $16.1 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $16.1 million, $16.5 million, and $16.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 319.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 105.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.99 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn 16.09 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 16.09 Mn
Mar 31, 2026 16.09 Mn
Dec 31, 2025 16.47 Mn
Dec 31, 2025 16.47 Mn
Sep 30, 2025 16.84 Mn
Sep 30, 2025 16.84 Mn
Jun 30, 2025 17.21 Mn
Jun 30, 2025 17.21 Mn
Mar 31, 2025 17.53 Mn
Mar 31, 2025 17.53 Mn
Dec 31, 2024 17.83 Mn
Dec 31, 2024 17.83 Mn
Sep 30, 2024 18.02 Mn
Sep 30, 2024 18.02 Mn
Jun 30, 2024 18.25 Mn
Jun 30, 2024 18.25 Mn
Mar 31, 2024 18.45 Mn
Mar 31, 2024 18.45 Mn
Dec 31, 2023 48.10 Mn
Dec 31, 2023 48.10 Mn
Sep 30, 2023 48.97 Mn
Sep 30, 2023 48.97 Mn
Jun 30, 2023 48.84 Mn
Jun 30, 2023 48.84 Mn
Mar 31, 2023 48.71 Mn
Mar 31, 2023 48.71 Mn
Dec 31, 2022 48.59 Mn
Dec 31, 2022 48.59 Mn
Sep 30, 2022 48.48 Mn
Sep 30, 2022 48.48 Mn
Jun 30, 2022 48.36 Mn
Jun 30, 2022 48.36 Mn
Mar 31, 2022 48.24 Mn
Mar 31, 2022 48.24 Mn
Dec 31, 2021 48.13 Mn
Dec 31, 2021 48.13 Mn
Sep 30, 2021 48.02 Mn
Sep 30, 2021 48.02 Mn
Jun 30, 2021 47.91 Mn
Jun 30, 2021 47.91 Mn
Mar 31, 2021 47.80 Mn
Mar 31, 2021 47.80 Mn
Dec 31, 2020 47.70 Mn
Dec 31, 2020 47.70 Mn
Sep 30, 2020 47.63 Mn
Sep 30, 2020 47.63 Mn
Jun 30, 2020 61.47 Mn
Jun 30, 2020 61.47 Mn
Mar 31, 2020 61.64 Mn
Mar 31, 2020 61.64 Mn
Dec 31, 2019 61.91 Mn
Dec 31, 2019 61.91 Mn
Sep 30, 2019 62.17 Mn
Sep 30, 2019 62.17 Mn
Jun 30, 2019 63.07 Mn
Jun 30, 2019 63.07 Mn
Sep 30, 2012 1.17 Mn
Sep 30, 2012 1.17 Mn
Jun 30, 2012 976,238.00
Jun 30, 2012 976,238.00
Mar 31, 2012 809,152.00
Mar 31, 2012 809,152.00
Dec 31, 2011 1.30 Mn
Dec 31, 2011 1.30 Mn
Sep 30, 2011 1.27 Mn
Sep 30, 2011 1.27 Mn
Jun 30, 2011 7,704.00
Jun 30, 2011 7,704.00